Websites, domains, hosts that links to amagpharma.com
Our database shows, that the website amagpharma.com is linked by a total of 9 websites.
Number of websites/domains displayed: 9
Results found: 9
Websites discovered:
INTRAROSA® - Treatment for Dyspareunia : INTRAROSA®http://pageoverview.com/website-report/intrarosahcp.com
For the treatment of moderate to severe dyspareunia due to menopause
- Expected expiration: June 1st in 2018
- Creation date: June 1st in 2017
- Renew date: June 1st in 2017
HCP Home │ Makena® (hydroxyprogesterone caproate injection)http://pageoverview.com/website-report/makenahcp.com
Learn about Makena (hydroxyprogesterone caproate injection): benefits & risk, dosing instructions, financial support, and resources.
- Expected expiration: July 30th in 2018
- Creation date: July 30th in 2014
- Renew date: June 19th in 2017
- Google Analytics: 55770527-2
bestoftheweb.orghttp://pageoverview.com/website-report/bestoftheweb.org
- Expected expiration: June 28th in 2018
- Creation date: June 28th in 1999
- Renew date: May 31st in 2017
Makena® | Makena (hydroxyprogesterone caproate injection)http://pageoverview.com/website-report/makena.com
Official site: learn more about Makena (hydroxyprogesterone caproate injection), its benefits & risks, dosing instructions, support, and financial aid programs.
- Expected expiration: April 28th in 2021
- Creation date: April 29th in 1998
- Renew date: March 16th in 2015
- Google Analytics: 55770527-1
Boston NAPShttp://pageoverview.com/website-report/bostonnaps.com
Boston NAPS is a team of Registered Nurses caring for expecting, new and experienced families. We provide expert care ranging from lactation consulting, sleep training, personal home visits, infant CPR/first aid and offer support groups and events around Boston.
- Expected expiration: August 24th in 2020
- Creation date: August 24th in 2011
- Renew date: November 9th in 2017
- Google Analytics: 82371400-1
Cutting Edge Informationhttp://pageoverview.com/website-report/cuttingedgeinfo.com
Cutting Edge Information provides decision support for pharma and medical device leaders with primary data, benchmarking reports & customized research
- Expected expiration: November 7th in 2024
- Creation date: November 7th in 2001
- Renew date: March 11th in 2016
- Google Analytics: 409467-11
Homehttp://pageoverview.com/website-report/feraheme.com
Feraheme (ferumoxytol) Injection for intravenous (IV) use is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease
- Expected expiration: November 26th in 2018
- Creation date: November 26th in 2007
- Renew date: April 10th in 2012